This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fujimura, M. Articles by Matsumoto, T. Search for Related Content PubMed PubMed Citation Articles by Fujimura, M. Articles by Matsumoto, T. Social Bookmarking                         What's this?

Aggressive Antiplatelet Therapy Before Coronary Stent Implantation in Acute Coronary Syndrome with Essential Thrombocythemia

A Case Report

Masashi Akaike, MD

Midori Kato, MD

Nobuyuki Takamori, MD

Masahiro Abe, MD

Takeshi Nishiuchi, MD

Hiroyuki Azuma, MD

Toshio Matsumoto, MD

A 52-year-old man was admitted to the hospital because of unstable angina pectoris. Coronary angiography revealed severe stenosis at a proximal site of the left anterior descending artery. Essential thrombocythemia (ET) was diagnosed on the basis of findings of marked thrombo cytosis (106 x 10⁴/µL) and an increased number of immature megakaryocytes in the bone marrow. Because hyperaggregability of platelets was demonstrated by an ex vivo platelet aggregation assay and by elevated plasma levels of β-thromboglobulin (β-TG) and platelet factor 4 (PF4), antiplatelet therapy with aspirin and ticlopidine and cytoreduction therapy with hydroxyurea were started. This combination treatment resulted in a decrease in the platelet count to less than 60 x 10⁴/µL and decreases in plasma levels of both β-TG and PF4 to almost normal values. Percutaneous coronary angioplasty and stenting were then performed success fully without thrombotic complications. These findings suggest that combination therapy with antiplatelet and cytoreduction agents before catheter intervention is useful for the prevention of thrombotic complications in patients with acute coronary syndrome associated with essential thrombocythemia.

Angiology, Vol. 54, No. 4, 485-490 (2003)
DOI: 10.1177/000331970305400414


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?